Transradial intervention in ST elevation myocardial infarction.

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Access

Background:

• Primary percutaneous coronary intervention (PPCI) is the gold standard for ST-elevation myocardial infarction (STEMI).
• Advances in antiplatelet/anticoagulant therapy reduce ischemic events but increase bleeding risk.
• Access site bleeding is a major peri-procedural complication in PCI.

Purpose of the Study:

• To review data on transradial access in STEMI PPCI.
• To discuss the benefits of radial artery access regarding bleeding and mortality.
• To explore challenges hindering universal adoption of radial access.

Main Methods:

• Review of national registry data and randomized controlled trials.
• Analysis of outcomes associated with transradial versus other access sites in STEMI PPCI.
• Discussion of antithrombotic/antiplatelet therapy interactions with access site choice.

Main Results:

• Transradial access is associated with significant reductions in major bleeding and mortality in STEMI PPCI.
• Radial access adoption has yielded mortality reductions comparable to the shift from thrombolysis to PPCI.
• Despite benefits, radial access adoption is not yet universal.

Conclusions:

• Transradial access is a safe and effective strategy for STEMI PPCI, reducing major bleeding and mortality.
• Further research is needed on the synergy between radial access and modern antithrombotic therapies.
• Overcoming obstacles to widespread radial access adoption is crucial for improving STEMI patient outcomes.